Key deliverables to understand transmission dynamics | • Understanding of the low levels of natural transmission |
 | • Clarification of the relationships between the different methods of measuring transmission to the mosquito |
 | • Better definition of the infectious reservoir, and its role in control programmes |
 | • Biomarkers to distinguish infectious from non-infectious hosts |
 | • Improved integration of laboratory and field experimentation and data |
Key deliverables to understand gametocyte biology | • New markers for commitment to gametocytogenesis |
 | • Improved methods for the purification of the different stages of sexual and sporogonic development. |
 | • Understanding of the pathways regulating sexual development (both gametocytogenesis and gametogenesis) |
 | • Understanding of parasite metabolism during sexual and sporogonic development |
 | • Improved understanding of the molecular basis of fertilization |
 | • Understanding of the mechanisms controlling gametocyte distribution in the host bloodstream. |
Key deliverables for translation | i) Vaccines |
 | • Understand the biological relevance of membrane feeding assays |
 | • Confirm structural and immunological fidelity of both current and new candidates |
 | • New platforms to enhance and prolong antibody responses |
 | • Designs for new field studies in a variety of endemic settings to evaluate TBVs alone and in combination |
 | • Develop bifunctional vaccines to attack both population bottlenecks (e.g. ookinete and liver schizont) |
 | ii) Drugs |
 | • Phenotypic screens for novel entities against gametocytes and ookinetes |
 | • New target-based screens |
 | • Understanding of the mode of action of primaquine |
 | • Identification of dual activity compounds from the known library of 25,000 compounds with schizonticidal activity |
 | • Identification of novel transmission-blocking-specific compounds, to explore possible combinations with blood schizonticides |
 | • Methods for sustained drug delivery |
 | iii) 'Out-of-the-box' |
 | • Reagents to modulate the mosquito innate immune system |
 | • Understanding of the roles of natural-, or genetically modified- microflora in regulating malaria transmission in the mosquito. |
Key research tools required | • Molecular markers for all stages of sexual development |
 | • Widespread availability of reagents for all 'genes' (GM parasites expressing tagged proteins or knockouts; monoclonal antibodies) |
 | • Improved access to high resolution, live imaging. |
 | • Publicly available archives of numerical and microscopic data |
 | • Wider access to transmission facilities |
 | • GM rodent parasites expressing key proteins/gene-products from human malaria parasites |
 | • Improved mathematical models of malaria transmission. |